Chronic mucus hypersecretion and the natural history of chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 193, Issue 6, 2016, Pages 602-603

  Lange, Peter ^a,b   Vestbo, Jørgen ^c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AIRWAY OBSTRUCTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COUGHING; EDITORIAL; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MUCUS SECRETION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SMOKING CESSATION; SPUTUM; CHRONIC BRONCHITIS; CHRONIC COUGH; DISEASE ASSOCIATION; HISTORY; AGING; FEMALE; LUNG; MALE; MUCUS; PATHOPHYSIOLOGY; PHYSIOLOGY; SMOKING;

AGING; FEMALE; HUMANS; LUNG; MALE; MUCUS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING;

EID: 84988703067     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201601-0001ED     Document Type: Editorial

References (13)

1. Fletcher CM, Pride NB. Definitions of emphysema, chronic bronchitis, asthma, and airflow obstruction: 25 years on from the Ciba symposium. Thorax 1984;39:81-85.
2. Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187:347-365.
3. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977;1:1645-1648.
4. Peto R, Speizer FE, Cochrane AL, Moore F, Fletcher CM, Tinker CM, Higgins IT, Gray RG, Richards SM, Gilliland J, et al. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease: results from 20 years of prospective observation. Am Rev Respir Dis 1983;128:491-500.
5. Kauffmann F, Drouet D, Lellouch J, Brille D. Twelve years spirometric changes among Paris area workers. Int J Epidemiol 1979;8: 201-212.
6. Annesi I, Kauffmann F. Is respiratory mucus hypersecretion really an innocent disorder? A 22-year mortality survey of 1,061 working men. Am Rev Respir Dis 1986;134:688-693.
7. Lange P, Nyboe J, Appleyard M, Jensen G, Schnohr P. Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes. Thorax 1990;45:579-585.
8. Prescott E, Lange P, Vestbo J. Chronic mucus hypersecretion in COPD and death from pulmonary infection. Eur Respir J 1995;8: 1333-1338.
9. Vestbo J, Prescott E, Lange P; Copenhagen City Heart Study Group. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Am J Respir Crit Care Med 1996;153:1530-1535.
10. Allinson JP, Hardy R, Donaldson GC, Shaheen SO, Kuh D, Wedzicha JA. The presence of chronic mucus hypersecretion across adult life in relation to chronic obstructive pulmonary disease development. Am J Respir Crit Care Med 2016;193:662-672.
11. Lange P, Groth S, Nyboe J, Mortensen J, Appleyard M, Schnohr P, Jensen G. Phlegm production in plain cigarette smokers who changed to filter cigarettes or quit smoking. J Intern Med 1990;228: 115-120.
12. Guerra S, Sherrill DL, Venker C, Ceccato CM, Halonen M, Martinez FD. Chronic bronchitis before age 50 years predicts incident airflow limitation and mortality risk. Thorax 2009;64: 894-900.
13. Vestbo J, Lange P. Can GOLD stage 0 provide information of prognostic value in chronic obstructive pulmonary disease? Am J Respir Crit Care Med 2002;166:329-332.